Continuous Glucose Monitor (CGM) Denied by Insurance? How to Appeal

Continuous Glucose Monitor (CGM) Denied by Insurance? How to Appeal

A continuous glucose monitor provides real-time blood sugar readings every few minutes, enabling people with diabetes to prevent dangerous highs and lows, reduce A1C, and avoid hospitalizations. CGMs are medically proven, guideline-supported, and increasingly recognized as standard of care. They are also routinely denied by insurers — a decision that is almost always reversible on appeal.

What CGMs Are and What They Cost

CGMs consist of a small sensor worn on the skin that measures glucose continuously and transmits readings to a receiver or smartphone. Leading products include:

• Dexcom G7: real-time readings every 5 minutes, 10-day wear, integration with insulin pumps and automated insulin delivery systems
• FreeStyle Libre 3 (Abbott): factory-calibrated, 14-day sensor, real-time alerts
• Medtronic Guardian 4: integrated with Medtronic insulin pump systems for closed-loop insulin delivery

Without insurance coverage, CGM systems cost $100 to $400 per month including sensors and transmitters. That is $1,200 to $4,800 per year — a significant financial burden that creates real barriers to optimal diabetes management.

Why CGM Claims Get Denied

"Not medically necessary" — fingerstick monitoring is sufficient. Insurers frequently argue that traditional blood glucose meters provide equivalent monitoring at a fraction of the cost. This argument is not supported by current clinical evidence or guideline consensus. CGMs detect glucose trends, not just point-in-time readings, and this trend data is clinically significant for preventing hypoglycemia and hyperglycemia.

Formulary exclusion. Some plans exclude CGMs entirely or restrict coverage to specific brands. If your specific CGM is excluded, a formulary exception appeal citing medical necessity is available.

Incorrect diagnosis code. Type 2 diabetes patients not on insulin are sometimes denied because the claim was submitted without documentation of insulin use or hypoglycemia risk. The correct ICD-10 coding is essential — E11.649 (Type 2 diabetes with hypoglycemia without coma) or E10.649 (Type 1 diabetes) versus E11.9 (Type 2 diabetes unspecified) produces very different outcomes.

Medicare-specific criteria not met. Medicare has specific coverage criteria under LCD L33822 that require documentation of insulin use or hypoglycemia unawareness.

ADA Standards of Care: The Clinical Guideline That Wins Appeals

The American Diabetes Association Standards of Medical Care in Diabetes — updated annually — is the authoritative clinical guideline for diabetes management. The 2024 ADA Standards state:

• CGM is recommended for all people with diabetes who use insulin (this includes both Type 1 and Type 2 insulin users)
• CGM should be considered for people with Type 2 diabetes not using insulin who have an A1C above 8% or who experience hypoglycemia
• Real-time CGM reduces A1C, reduces hypoglycemic events, and improves time-in-range compared to self-monitoring with fingersticks

Cite these specific recommendations by section in your appeal letter. When your physician's clinical recommendation aligns precisely with the ADA standard of care, the insurer's "not medically necessary" argument collapses.

Medicare Coverage: LCD L33822

For Medicare beneficiaries, CGM coverage is governed by Local Coverage Determination L33822 (Glucose Monitors). Medicare covers CGMs (classified as Durable Medical Equipment) when:

• The patient has diabetes
• The treating practitioner has ordered the CGM
• The patient is insulin-treated or has documented hypoglycemia unawareness

If your Medicare CGM claim was denied, verify that the order and documentation match LCD L33822 criteria precisely. The prescribing physician's records must document insulin use or hypoglycemia history in the clinical notes.

Building a Strong Commercial Plan Appeal

For commercial (employer-sponsored or marketplace) insurance, a three-step approach works consistently:

Step 1: Verify coding and documentation. Confirm the claim used the correct ICD-10 code. Insulin use must be documented in the medical record. If hypoglycemia events contributed to the decision, those must appear in clinical notes, not just be mentioned verbally.

Step 2: Physician letter citing ADA guidelines. Your endocrinologist or primary care physician should write a letter that documents: your diabetes type and severity, current A1C, insulin regimen (including frequency of dosing adjustments), any hypoglycemic episodes, and an explicit reference to the ADA Standards of Care recommending CGM for patients with your profile.

Step 3: Request and address the insurer's Clinical Policy Bulletin. Every insurer publishes coverage criteria for CGMs. Request a copy. Address each criterion in your appeal letter, documenting that you meet it. If the CPB requires insulin use — document insulin use. If it requires A1C above a threshold — include your lab results. Remove every gap between their criteria and your documentation.

Prior Authorization Denied: How to Appeal" class="auto-link">Prior Authorization Tips

Most commercial plans require prior authorization for CGMs. PA requirements typically include:

• Diabetes diagnosis documentation
• Current medication list showing insulin use (or documented hypoglycemia unawareness)
• Prescribing physician's order and clinical notes
• Physician attestation of medical necessity

If the initial PA was denied, the appeal should be filed by the prescribing physician with the clinical documentation above. Many PA denials are reversed at first appeal when complete documentation is submitted.

Documentation Checklist

• Denial letter with specific denial reason and coverage criteria cited
• Physician letter documenting diabetes type, A1C, insulin regimen, and hypoglycemia history
• Lab results: most recent HbA1c, fasting glucose
• Medical records documenting hypoglycemic episodes (if applicable)
• ADA Standards of Care pages supporting CGM for your profile
• Insurer's Clinical Policy Bulletin for CGM coverage
• Correct ICD-10 codes: E10.649 (Type 1) or E11.649 (Type 2 with hypoglycemia)
• Medicare LCD L33822 (if Medicare-insured)
• Prior CGM prescription and physician order

Fight Back With ClaimBack

ClaimBack analyzes your CGM denial against ADA guidelines and your insurer's own coverage criteria, then generates an appeal package your physician can submit immediately.

Start your free appeal analysis at ClaimBack

Free analysis · No credit card required · Takes 3 minutes

Related Reading

• What Is Medical Necessity?
• How to Write an Insurance Appeal Letter
• Common Reasons Insurance Claims Are Denied